The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients
Open accessAbstract
Background: The CD40/CD40L system, a key regulator and amplifier of immune reactivity, is activated in inflammatory bowel disease (IBD) mucosa. Aims: To determine whether plasma levels of sCD40L are elevated in Crohn’s disease (CD) and ulcerative colitis (UC) patients compared with normal controls, to investigate the cellular source of sCD40L, and to explore CD40L induction mechanisms. Patients: CD, UC, and normal control subjects were studied. Methods: The concentration of sCD40L in plasma and supernatants of freshly isolated platelets and autologous peripheral blood T cells (PBT) was measured by ELISA. Surface CD40L expression level was measured by flow cytometry in resting and thrombin activated platelets, and unstimulated and CD3/CD28 stimulated PBT before and after coculture with human intestinal microvascular endothelial cells (HIMEC). Results: Compared with normal controls, plasma sCD40L levels were significantly higher in both CD and UC patients and proportional to the extent of mucosal inflammation. Platelets from IBD patients displayed a significantly higher surface CD40L expression than those from control subjects, and released greater amounts of sCD40L than autologous PBT. Contact with IL-1β activated HIMEC induced significant upregulation of CD40L surface expression and release by platelets. Conclusions: Elevated levels of sCD40L in the circulation of IBD patients reflect enhanced surface expression and release of CD40L by platelets. This phenomenon translates to an increased platelet activation state apparently induced by passage through an inflamed mucosal microvascular bed, a conclusion supported by the positive correlation of plasma sCD40L levels with the extent of anatomical involvement by IBD. These results suggest that platelet-endothelial interactions critically contribute to activation of the CD40 pathway in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY
Harvey, R. F., & Bradshaw, J. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92767-1 · Cited by 2,959
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Self-citationvan Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,404
Soluble CD40 Ligand in Acute Coronary Syndromes
Heeschen, C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E., Zeiher, A. M., & Simoons, M. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022600 · Cited by 828
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review
Schönbeck*RID="*"ID="*" Correspondi, U., & Libby, P. (2001) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000776 · Cited by 737
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism
André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726
Sutherland, L. R., Martin, F., Greer, S., Robinson, M., Greenberger, N., Saibil, F., Martin, T., Sparr, J., Prokipchuk, E., & Borgen, L. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90621-4 · Cited by 677
Platelet-Derived CD40L: The Switch-Hitting Player of Cardiovascular Disease
André, P., Nannizzi-Alaimo, L., Prasad, S. K., & Phillips, D. R. (2002) · Circulation · doi:10.1161/01.cir.0000028962.04520.01 · Cited by 567
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Soluble CD40L and Cardiovascular Risk in Women
Schönbeck, U., Varo, N., Libby, P., Buring, J., & Ridker, P. M. (2001) · Circulation · doi:10.1161/hc4401.099447 · Cited by 459
Schmitz, G., Rothe, G., Ruf, A., Barlage, S., Tschöpe, D., Clemetson, K. J., Goodall, A. H., Michelson, A. D., Nurden, A. T., Shankey, V. T., et al. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615088 · Cited by 370
Platelet-Endothelium Interactions
Flier, J. S., Underhill, L. H., Ware, J. A., & Heistad, D. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303043280907 · Cited by 250
Kalbas, M., Willuweit, A., Henn, V., Kroczek, R., Müller-Berghaus, G., & Slupsky, J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615402 · Cited by 241
Platelets circulate in an activated state in inflammatory bowel disease
Collins, C. E., Cahill, M. R., Newland, A. C., & Rampton, D. S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90741-2 · Cited by 227
Expression of vascular adhesion molecules in inflammatory bowel disease
Koizumi, M., King, N., Lobb, R., Benjamin, C., & Podolsky, D. K. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90015-q · Cited by 219
Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions
Fiocchi, C. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g769 · Cited by 216
Self-citationDanese, S., de la Motte, C., Sturm, A., Vogel, J. D., West, G. A., Strong, S. A., Katz, J. A., & Fiocchi, C. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00289-0 · Cited by 204
Self-citationBinion, D., West, G., Ina, K., Ziats, N., Emancipator, S., & Fiocchi, C. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178682 · Cited by 200
Self-citationKlinger, M. H. F. (1997) · Anatomy and Embryology · doi:10.1007/s004290050075 · Cited by 197
Atherosclerosis: The emerging role of inflammation and the CD40–CD40 ligand system
Phipps, R. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.6930 · Cited by 197
The soluble CD40 ligand sCD154 in systemic lupus erythematosus
Kato, K., Santana-Sahagún, E., Rassenti, L. Z., Weisman, M. H., Tamura, N., Kobayashi, S., Hashimoto, H., & Kipps, T. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7014 · Cited by 196
Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera
Vakkalanka, R., Woo, C. J., Kirou, K. A., Koshy, M., Berger, D., & Crow, M. K. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<871::aid-anr5>3.0.co;2-j · Cited by 163
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
Garlichs, C. D., Eskafi, S., Raaz, D., Schmidt, A., Ludwig, J., Herrmann, M., Klinghammer, L., Daniel, W. G., & Schmeisser, A. (2001) · Heart · doi:10.1136/heart.86.6.649 · Cited by 162
Liu, Z., Colpaert, S. A., D’Haens, G., Kasran, A., de Boer, M., Rutgeerts, P., Geboes, K. J., & Ceuppens, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.4049 · Cited by 146
Liu, Z., Geboes, K. J., Colpaert, S. A., Overbergh, L., Mathieu, C., Heremans, H., de Boer, M., Boon, L., D’Haens, G., Rutgeerts, P. J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.6005 · Cited by 126
COLLINS, C. E., & Rampton, D. S. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.153328000.x · Cited by 120
Human Native Soluble CD40L Is a Biologically Active Trimer, Processed Inside Microsomes
Pietravalle, F., Lecoanet-Henchoz, S., Blasey, H. D., Aubry, J., Elson, G., Edgerton, M. D., Bonnefoy, J., & Gauchat, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.5965 · Cited by 114
CD40‐CD40 ligand interaction in autoimmune disease
Datta, S. K., & Kalled, S. L. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401002 · Cited by 105
de Jong, Y. P., Comiskey, M., Kalled, S. L., Mizoguchi, E., Flavell, R. A., Bhan, A. K., & Terhorst, C. (2000) · Gastroenterology · doi:10.1053/gast.2000.16485 · Cited by 92
Immunological Basis of Inflammatory Bowel Disease: Role of the Microcirculation
Laroux, F. S., & Grisham, M. B. (2001) · Microcirculation · doi:10.1111/j.1549-8719.2001.tb00177.x · Cited by 80
Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
Tamura, N., Kobayashi, S., Kato, K., et al. (2001) · PubMed · Cited by 62
Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases
Ludwiczek, O., Kaser, A., & Tilg, H. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-002-0425-4 · Cited by 55
p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling
Sturm, A., Itoh, J., Jacobberger, J. W., & Fiocchi, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14967 · Cited by 50
Self-citationSoluble CD40 ligand in acute coronary syndromes
Heeschen, C., Dimmeler, S., & Hamm, C. W. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00138-7 · Cited by 44
Critical role of caspases in the regulation of apoptosis and proliferation of mucosal T cells
Sturm, A., Mohr, S., & Fiocchi, C. (2002) · Gastroenterology · doi:10.1053/gast.2002.32996 · Cited by 34
Self-citationImmunological Basis of Inflammatory Bowel Disease: Role of the Microcirculation
Laroux, F. S., & Grisham, M. B. (2001) · Microcirculation · doi:10.1038/sj.mn.7800095 · Cited by 23
Cited by
Platelets at the interface of thrombosis, inflammation, and cancer
Franco, A. T., Corken, A., & Ware, J. (2015) · Blood · doi:10.1182/blood-2014-08-531582 · Cited by 691
Inflammation and Coagulation in Inflammatory Bowel Disease: The Clot Thickens
Danese, S., Papa, A., Saibeni, S., Repici, A., Malesci, A., & Vecchi, M. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00943.x · Cited by 384
Self-citationAngiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis
Danese, S., Sans, M., de la Motte, C., Graziani, C., West, G., Phillips, M. H., Pola, R., Rutella, S., Willis, J., Gasbarrini, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.054 · Cited by 374
Self-citationImmunogenetics of autoimmune thyroid diseases: a comprehensive review
Lee, H. J., Li, C. W., Hammerstad, S. S., Stefan, M., & Tomer, Y. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.07.009 · Cited by 351
“including systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and IgE-mediated asthma [50, 66-69].”
BackgroundTargeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
Karnell, J. L., Rieder, S. A., Ettinger, R., & Kolbeck, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.005 · Cited by 334
Metadata
- Authors
- Danese, S., Katz, J. A., Saibeni, S., Papa, A., Gasbarrini, A., Vecchi, M., & Fiocchi, C.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2003-09-11
- Volume
- 52
- Issue
- 10
- Pages
- 1435-1441
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2105076697
- Cited by
- 257
- References
- 36
- FWCI
- 8.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.